Comparison of standard triple drugs therapy and sequential regimen for Helicobacter- pylori eradicatio
Phase 2
- Conditions
- Dyspepsia.Dyspepsia
- Registration Number
- IRCT201104226030N5
- Lead Sponsor
- Vice-chancellor for research of Hamadan university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
Inclusion criteria : patients in whom Helicobacter pylori infection was detected by endoscopic method, serology, and urease breathe test with C14.
Exclusion criteria:
past history of Helicobacter pylori infection treatment , upper gastero- intestinal surgery,
Gasteric cancer,
renal or liver failure,
breast feeding & pregnant woman.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eradication of Helicobacter pylori. Timepoint: 4-6 weeks after treatment. Method of measurement: Rate of eradication by Urease breathe test with C14.
- Secondary Outcome Measures
Name Time Method